HANGZHOU, China, Feb. 28, 2021 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd., (Sciwind), a clinical-stage, fast-growing biotech focusing on research and development of innovative biologics, today announced that XW003, a potential candidate for the treatment of non-alcoholic...
from PR Newswire: https://ift.tt/3bKZ7Gx
No comments:
Post a Comment